2015-2027 Global Microbiome Drugs Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

March 2020 | 114 pages | ID: 29A59E1F6CDFEN
Maia Research

Abstracts

The worldwide market for Microbiome Drugs is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Rebiotix, Inc.
Second Genome
Ritter Pharmaceuticals
MaaT Pharma
Enterome Bioscience
OpenBiome
MicroBiome Therapeutics LLC
Seres Therapeutics

Major Types Covered
Probiotics
Prebiotics
Small molecules
Biological drugs

Major Applications Covered
Autoimmune diseases
Inflammatory bowel diseases
Cancer
Others

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Microbiome Drugs Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Microbiome Drugs Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE MICROBIOME DRUGS MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL MICROBIOME DRUGS MARKET-SEGMENTATION BY TYPE

5.1 Probiotics
5.2 Prebiotics
5.3 Small molecules
5.4 Biological drugs

6 GLOBAL MICROBIOME DRUGS MARKET-SEGMENTATION BY APPLICATION

6.1 Autoimmune diseases
6.2 Inflammatory bowel diseases
6.3 Cancer
6.4 Others

7 GLOBAL MICROBIOME DRUGS MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Rebiotix, Inc.
  8.1.1 Rebiotix, Inc. Profile
  8.1.2 Rebiotix, Inc. Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Rebiotix, Inc. Product/Solution Launches and Enhancements Analysis
  8.1.4 Rebiotix, Inc. Business Overview/Recent Development/Acquisitions
8.2 Second Genome
  8.2.1 Second Genome Profile
  8.2.2 Second Genome Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Second Genome Product/Solution Launches and Enhancements Analysis
  8.2.4 Second Genome Business Overview/Recent Development/Acquisitions
8.3 Ritter Pharmaceuticals
  8.3.1 Ritter Pharmaceuticals Profile
  8.3.2 Ritter Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Ritter Pharmaceuticals Product/Solution Launches and Enhancements Analysis
  8.3.4 Ritter Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.4 MaaT Pharma
  8.4.1 MaaT Pharma Profile
  8.4.2 MaaT Pharma Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 MaaT Pharma Product/Solution Launches and Enhancements Analysis
  8.4.4 MaaT Pharma Business Overview/Recent Development/Acquisitions
8.5 Enterome Bioscience
  8.5.1 Enterome Bioscience Profile
  8.5.2 Enterome Bioscience Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Enterome Bioscience Product/Solution Launches and Enhancements Analysis
  8.5.4 Enterome Bioscience Business Overview/Recent Development/Acquisitions
8.6 OpenBiome
  8.6.1 OpenBiome Profile
  8.6.2 OpenBiome Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 OpenBiome Product/Solution Launches and Enhancements Analysis
  8.6.4 OpenBiome Business Overview/Recent Development/Acquisitions
8.7 MicroBiome Therapeutics LLC
  8.7.1 MicroBiome Therapeutics LLC Profile
  8.7.2 MicroBiome Therapeutics LLC Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 MicroBiome Therapeutics LLC Product/Solution Launches and Enhancements Analysis
  8.7.4 MicroBiome Therapeutics LLC Business Overview/Recent Development/Acquisitions
8.8 Seres Therapeutics
  8.8.1 Seres Therapeutics Profile
  8.8.2 Seres Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Seres Therapeutics Product/Solution Launches and Enhancements Analysis
  8.8.4 Seres Therapeutics Business Overview/Recent Development/Acquisitions

9 GLOBAL MICROBIOME DRUGS MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Microbiome Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Microbiome Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Microbiome Drugs Production Analysis from 2015-2020
10.4 North America Microbiome Drugs Consumption Analysis from 2015-2020
10.5 North America Microbiome Drugs Import and Export from 2015-2020
10.6 North America Microbiome Drugs Value, Production and Market Share by Type (2015-2020)
10.7 North America Microbiome Drugs Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Microbiome Drugs by Country (United States, Canada)
  10.8.1 North America Microbiome Drugs Sales by Country (2015-2020)
  10.8.2 North America Microbiome Drugs Consumption Value by Country (2015-2020)
10.9 North America Microbiome Drugs Market PEST Analysis

11 EUROPE

11.1 Europe Microbiome Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Microbiome Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Microbiome Drugs Production Analysis from 2015-2020
11.4 Europe Microbiome Drugs Consumption Analysis from 2015-2020
11.5 Europe Microbiome Drugs Import and Export from 2015-2020
11.6 Europe Microbiome Drugs Value, Production and Market Share by Type (2015-2020)
11.7 Europe Microbiome Drugs Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Microbiome Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Microbiome Drugs Sales by Country (2015-2020)
  11.8.2 Europe Microbiome Drugs Consumption Value by Country (2015-2020)
11.9 Europe Microbiome Drugs Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Microbiome Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Microbiome Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Microbiome Drugs Production Analysis from 2015-2020
12.4 Asia-Pacific Microbiome Drugs Consumption Analysis from 2015-2020
12.5 Asia-Pacific Microbiome Drugs Import and Export from 2015-2020
12.6 Asia-Pacific Microbiome Drugs Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Microbiome Drugs Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Microbiome Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Microbiome Drugs Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Microbiome Drugs Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Microbiome Drugs Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Microbiome Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Microbiome Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Microbiome Drugs Production Analysis from 2015-2020
13.4 Latin America Microbiome Drugs Consumption Analysis from 2015-2020
13.5 Latin America Microbiome Drugs Import and Export from 2015-2020
13.6 Latin America Microbiome Drugs Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Microbiome Drugs Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Microbiome Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Microbiome Drugs Sales by Country (2015-2020)
  13.8.2 Latin America Microbiome Drugs Consumption Value by Country (2015-2020)
13.9 Latin America Microbiome Drugs Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Microbiome Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Microbiome Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Microbiome Drugs Production Analysis from 2015-2020
14.4 Middle East & Africa Microbiome Drugs Consumption Analysis from 2015-2020
14.5 Middle East & Africa Microbiome Drugs Import and Export from 2015-2020
14.6 Middle East & Africa Microbiome Drugs Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Microbiome Drugs Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Microbiome Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Microbiome Drugs Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Microbiome Drugs Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Microbiome Drugs Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL MICROBIOME DRUGS MARKET FROM 2020-2027

15.1 Future Forecast of the Global Microbiome Drugs Market from 2020-2027 Segment by Region
15.2 Global Microbiome Drugs Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Microbiome Drugs Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Microbiome Drugs Market Value ($) and Growth Rate of Microbiome Drugs from 2015-2027
Global Microbiome Drugs Production and Growth Rate Segment by Product Type from 2015-2027
Global Microbiome Drugs Consumption and Growth Rate Segment by Application from 2015-2027
Figure Microbiome Drugs Picture
Table Product Specifications of Microbiome Drugs
Table Driving Factors for this Market
Table Industry News of Microbiome Drugs Market
Figure Value Chain Status of Microbiome Drugs
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Microbiome Drugs Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Microbiome Drugs Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Probiotics of Microbiome Drugs
Figure Prebiotics of Microbiome Drugs
Figure Small molecules of Microbiome Drugs
Figure Biological drugs of Microbiome Drugs
Table Global Microbiome Drugs Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Microbiome Drugs Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Autoimmune diseases of Microbiome Drugs
Figure Inflammatory bowel diseases of Microbiome Drugs
Figure Cancer of Microbiome Drugs
Figure Others of Microbiome Drugs
Table Global Microbiome Drugs Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Microbiome Drugs Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Microbiome Drugs
Figure Online Channel of Microbiome Drugs
Table Rebiotix, Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Rebiotix, Inc. Sales and Growth Rate from 2015-2020
Figure Rebiotix, Inc. Revenue ($) and Global Market Share from 2015-2020
Table Rebiotix, Inc. Microbiome Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Second Genome Profile (Company Name, Plants Distribution, Sales Region)
Figure Second Genome Sales and Growth Rate from 2015-2020
Figure Second Genome Revenue ($) and Global Market Share from 2015-2020
Table Second Genome Microbiome Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Ritter Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Ritter Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Ritter Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Ritter Pharmaceuticals Microbiome Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table MaaT Pharma Profile (Company Name, Plants Distribution, Sales Region)
Figure MaaT Pharma Sales and Growth Rate from 2015-2020
Figure MaaT Pharma Revenue ($) and Global Market Share from 2015-2020
Table MaaT Pharma Microbiome Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Enterome Bioscience Profile (Company Name, Plants Distribution, Sales Region)
Figure Enterome Bioscience Sales and Growth Rate from 2015-2020
Figure Enterome Bioscience Revenue ($) and Global Market Share from 2015-2020
Table Enterome Bioscience Microbiome Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table OpenBiome Profile (Company Name, Plants Distribution, Sales Region)
Figure OpenBiome Sales and Growth Rate from 2015-2020
Figure OpenBiome Revenue ($) and Global Market Share from 2015-2020
Table OpenBiome Microbiome Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table MicroBiome Therapeutics LLC Profile (Company Name, Plants Distribution, Sales Region)
Figure MicroBiome Therapeutics LLC Sales and Growth Rate from 2015-2020
Figure MicroBiome Therapeutics LLC Revenue ($) and Global Market Share from 2015-2020
Table MicroBiome Therapeutics LLC Microbiome Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Seres Therapeutics Profile (Company Name, Plants Distribution, Sales Region)
Figure Seres Therapeutics Sales and Growth Rate from 2015-2020
Figure Seres Therapeutics Revenue ($) and Global Market Share from 2015-2020
Table Seres Therapeutics Microbiome Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Microbiome Drugs Production Value ($) by Region from 2015-2020
Table Global Microbiome Drugs Production Value Share by Region from 2015-2020
Table Global Microbiome Drugs Production by Region from 2015-2020
Table Global Microbiome Drugs Consumption Value ($) by Region from 2015-2020
Table Global Microbiome Drugs Consumption by Region from 2015-2020
Table North America Microbiome Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Microbiome Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Microbiome Drugs Import and Export from 2015-2020
Table North America Microbiome Drugs Value ($) by Type (2015-2020)
Table North America Microbiome Drugs Production by Type (2015-2020)
Table North America Microbiome Drugs Consumption by Application (2015-2020)
Table North America Microbiome Drugs Consumption by Country (2015-2020)
Table North America Microbiome Drugs Consumption Value ($) by Country (2015-2020)
Figure North America Microbiome Drugs Market PEST Analysis
Table Europe Microbiome Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Microbiome Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Microbiome Drugs Import and Export from 2015-2020
Table Europe Microbiome Drugs Value ($) by Type (2015-2020)
Table Europe Microbiome Drugs Production by Type (2015-2020)
Table Europe Microbiome Drugs Consumption by Application (2015-2020)
Table Europe Microbiome Drugs Consumption by Country (2015-2020)
Table Europe Microbiome Drugs Consumption Value ($) by Country (2015-2020)
Figure Europe Microbiome Drugs Market PEST Analysis
Table Asia-Pacific Microbiome Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Microbiome Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Microbiome Drugs Import and Export from 2015-2020
Table Asia-Pacific Microbiome Drugs Value ($) by Type (2015-2020)
Table Asia-Pacific Microbiome Drugs Production by Type (2015-2020)
Table Asia-Pacific Microbiome Drugs Consumption by Application (2015-2020)
Table Asia-Pacific Microbiome Drugs Consumption by Country (2015-2020)
Table Asia-Pacific Microbiome Drugs Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Microbiome Drugs Market PEST Analysis
Table Latin America Microbiome Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Microbiome Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Microbiome Drugs Import and Export from 2015-2020
Table Latin America Microbiome Drugs Value ($) by Type (2015-2020)
Table Latin America Microbiome Drugs Production by Type (2015-2020)
Table Latin America Microbiome Drugs Consumption by Application (2015-2020)
Table Latin America Microbiome Drugs Consumption by Country (2015-2020)
Table Latin America Microbiome Drugs Consumption Value ($) by Country (2015-2020)
Figure Latin America Microbiome Drugs Market PEST Analysis
Table Middle East & Africa Microbiome Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Microbiome Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Microbiome Drugs Import and Export from 2015-2020
Table Middle East & Africa Microbiome Drugs Value ($) by Type (2015-2020)
Table Middle East & Africa Microbiome Drugs Production by Type (2015-2020)
Table Middle East & Africa Microbiome Drugs Consumption by Application (2015-2020)
Table Middle East & Africa Microbiome Drugs Consumption by Country (2015-2020)
Table Middle East & Africa Microbiome Drugs Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Microbiome Drugs Market PEST Analysis
Table Global Microbiome Drugs Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Microbiome Drugs Production and Growth Rate Forecast by Region (2020-2027)
Table Global Microbiome Drugs Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Microbiome Drugs Production and Growth Rate Forecast by Type (2020-2027)
Table Global Microbiome Drugs Consumption and Growth Rate Forecast by Application (2020-2027)